The Myland Pharm-branded base builds on more than a decade of cooperation with Vinsce Bio-Pharm, bringing ingredient development, process scale-up, technology services, and manufacturing closer together.
ZHANGJIAGANG, China — September 18, 2026 — Suzhou Myland Nutraceuticals Inc. (“Myland Pharm”) has officially unveiled its R&D and Industrialization Collaboration Base at Vinsce Bio-Pharm (Suzhou) Co., Ltd. (“Vinsce Bio-Pharm”) in Zhangjiagang, China. The new base builds on more than a decade of technical and manufacturing cooperation between the two companies and provides a dedicated platform for supporting nutraceutical ingredient development and industrial applications.
Myland Pharm and Vinsce Bio-Pharm have maintained an established working relationship for more than ten years across ingredient development, process coordination, manufacturing support, or supply collaboration. Over this period, the companies have developed a practical understanding of each other’s technical and manufacturing capabilities. The new base provides a more defined framework for continuing that work, with a focus on connecting ingredient development with process and manufacturing requirements.
Through the platform, Myland Pharm will coordinate with Vinsce Bio-Pharm and other technical partners, where appropriate, on project activities from technical evaluation and process development through scale-up studies, quality assessment, application development, or manufacturing support. Specific activities will vary by project and will be carried out in accordance with applicable quality and compliance requirements.
For nutraceutical ingredient projects, this connection between R&D and manufacturing can provide a more practical route for addressing technical requirements as projects progress. It can also facilitate communication across product development, process engineering, technology services, and customer-facing teams, helping align technical specifications with application and production needs.
“The Collaboration Base reflects the strong foundation we have built through more than a decade of cooperation with Vinsce Bio-Pharm,” said Gledon Fan, Founder of Myland Pharm. “With a dedicated platform for technical and manufacturing collaboration, our teams can work more closely as projects move form ingredient development toward scale-up and application. We see this as an opportunity to understand and respond more effectively to customer requirements while supporting the development of practical, application-oriented ingredient solutions.”
The establishment of the base reflects Myland Pharm’s broader approach to connecting R&D, manufacturing, quality, and application development. The company will continue to work with industry and technical partners to support nutraceutical projects across different stages of development, with an emphasis on consistent quality, scalable processes, technical performance, and practical applications.
For inquiries about ingredient development, technical documentation, application projects, or supply cooperation, please contact the Myland Pharm team through the company’s official website.
About Myland Pharm
Suzhou Myland Nutraceuticals Inc. develops and supplies nutraceutical ingredients, pharmaceutical products, small molecules, and biological raw materials for customers in the life science and health-related industries. We support customers and industry partners through ingredient development, technical coordination, application support, and supply cooperation, with experience across approximately 100 complex manufacturing service projects.
Post time: Sep-18-2026
